209 related articles for article (PubMed ID: 34089097)
1. Observational study investigating Ectoin
Werkhäuser N; Bilstein A; Mahlstedt K; Sonnemann U
Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1371-1381. PubMed ID: 34089097
[TBL] [Abstract][Full Text] [Related]
2. A prospective, controlled study of SNS01 (ectoine nasal spray) compared to BNO-101 (phytotherapeutic dragées) in patients with acute rhinosinusitis.
Eichel A; Wittig J; Shah-Hosseini K; Mösges R
Curr Med Res Opin; 2013 Jul; 29(7):739-46. PubMed ID: 23621514
[TBL] [Abstract][Full Text] [Related]
3. Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal Sprays.
Mösges R; Shah-Hosseini K; Hucke HP; Joisten MJ
Adv Ther; 2017 Aug; 34(8):1850-1858. PubMed ID: 28695477
[TBL] [Abstract][Full Text] [Related]
4. A real-world study of quality of life following treatment with xylometazoline hydrochloride in individuals with common cold.
Hagen M; Clark K; Kalita P; Serra G; Sanchez E; Varbiro G; Albasser MM
Ther Adv Respir Dis; 2024; 18():17534666241228927. PubMed ID: 38372128
[TBL] [Abstract][Full Text] [Related]
5. [Advance in therapy of acute rhinitis--comparison of efficacy and safety of xylometazoline in combination xylometazoline-dexpanthenol in patients with acute rhinitis].
Kehrl W; Sonnemann U; Dethlefsen U
Laryngorhinootologie; 2003 Apr; 82(4):266-71. PubMed ID: 12717602
[TBL] [Abstract][Full Text] [Related]
6. The value of Ems Mineral Salts in the treatment of rhinosinusitis in children. Prospective study on the efficacy of mineral salts versus xylometazoline in the topical nasal treatment of children.
Michel O; Essers S; Heppt WJ; Johannssen V; Reuter W; Hommel G
Int J Pediatr Otorhinolaryngol; 2005 Oct; 69(10):1359-65. PubMed ID: 16098615
[TBL] [Abstract][Full Text] [Related]
7. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
Eccles R; Martensson K; Chen SC
Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
[TBL] [Abstract][Full Text] [Related]
8. Safety of the use of xylometazoline nasal spray in young children undergoing lacrimal surgery: an observational study.
Joganathan V; Beigi B
Eur J Ophthalmol; 2018 May; 28(3):279-281. PubMed ID: 29077183
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection.
Eccles R; Pedersen A; Regberg D; Tulento H; Borum P; Stjärne P
Am J Rhinol; 2007; 21(1):40-5. PubMed ID: 17283559
[TBL] [Abstract][Full Text] [Related]
10. Novel nasal formulation of xylometazoline with hyaluronic acid: In vitro ciliary beat frequency study.
Tratnjek L; Simić L; Vukelić K; Knežević Z; Kreft ME
Eur J Pharm Biopharm; 2023 Nov; 192():136-146. PubMed ID: 37804998
[TBL] [Abstract][Full Text] [Related]
11. [Improving wound healing after nose surgery by combined administration of xylometazoline and dexpanthenol].
Kehrl W; Sonnemann U
Laryngorhinootologie; 2000 Mar; 79(3):151-4. PubMed ID: 10763172
[TBL] [Abstract][Full Text] [Related]
12. Comparison of nasal hyperosmolar xylitol and xylometazoline solutions on quality of life in patients with inferior turbinate hypertrophy secondary to nonallergic rhinitis.
Cingi C; Birdane L; Ural A; Oghan F; Bal C
Int Forum Allergy Rhinol; 2014 Jun; 4(6):475-9. PubMed ID: 24574278
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of a new nasal spray formulation containing hyaluronate and tobramycin in cystic fibrosis patients with bacterial rhinosinusitis.
Di Cicco M; Alicandro G; Claut L; Cariani L; Luca N; Defilippi G; Costantini D; Colombo C
J Cyst Fibros; 2014 Jul; 13(4):455-60. PubMed ID: 24656944
[TBL] [Abstract][Full Text] [Related]
14. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
Dorn M; Hofmann W; Knick E
HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
[TBL] [Abstract][Full Text] [Related]
15. The nasal decongestant effect of xylometazoline in the common cold.
Eccles R; Eriksson M; Garreffa S; Chen SC
Am J Rhinol; 2008; 22(5):491-6. PubMed ID: 18655753
[TBL] [Abstract][Full Text] [Related]
16. Tolerability and effects on quality of life of liposomal nasal spray treatment compared to nasal ointment containing dexpanthenol or isotonic NaCl spray in patients with rhinitis sicca.
Hahn C; Böhm M; Allekotte S; Mösges R
Eur Arch Otorhinolaryngol; 2013 Sep; 270(9):2465-72. PubMed ID: 23371540
[TBL] [Abstract][Full Text] [Related]
17. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.
Castellano F; Mautone G
Drugs Exp Clin Res; 2002; 28(1):27-35. PubMed ID: 12073765
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial.
Dolor RJ; Witsell DL; Hellkamp AS; Williams JW; Califf RM; Simel DL;
JAMA; 2001 Dec; 286(24):3097-105. PubMed ID: 11754675
[TBL] [Abstract][Full Text] [Related]
19. Immediate effect of benzalkonium chloride in decongestant nasal spray on the human nasal mucosal temperature.
Lindemann J; Leiacker R; Wiesmiller K; Rettinger G; Keck T
Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):357-61. PubMed ID: 15270822
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
